UBS Group’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74K | Buy |
|
|||||
|
2025
Q1 | $30.2K | Buy |
|
|||||
|
2024
Q4 | $49.9K | Buy |
|
|||||
|
2024
Q3 | $25.6K | Buy |
|
|||||
|
2024
Q2 | $42.7K | Sell |
|
|||||
|
2024
Q1 | $629K | Sell |
|
|||||
|
2023
Q4 | $69K | Buy |
|
|||||
|
2023
Q3 | $82.6K | Buy |
|
|||||
|
2023
Q2 | $24.4K | Buy |
|
|||||
|
2023
Q1 | $190 | Sell |
|
|||||
|
2022
Q4 | $1.69K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $15K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $14K | Buy |
|